Sugahara M, Tanaka S, Tanaka T, Saito H, et al. Prolyl Hydroxylase Domain Inhibitor Protects against Metabolic Disorders and Associated Kidney Disease in Obese Type 2 Diabetic Mice. J Am Soc Nephrol 2020 Jan 29. pii: ASN.2019060582. doi: 10.1681/ASN.2019060582.
PMID: 31996409